Literature DB >> 31845023

Genetic polymorphism patterns suggest a genetic driven inflammatory response as pathogenesis in appendicitis.

Jan Dimberg1, Marie Rubér2, Marita Skarstedt3, Manne Andersson2,4, Roland E Andersson5,6.   

Abstract

PURPOSE: The pathogenesis of appendicitis is not well understood. Environmental factors are regarded most important, but epidemiologic findings suggest a role of inflammatory and genetic mechanisms. This study determines the association of single nucleotide polymorphisms (SNPs) of inflammatory genes with appendicitis.
METHODS: As part of a larger prospective study on the diagnostic value of inflammatory variables in appendicitis, the genotype frequency of 28 polymorphisms in 26 inflammatory response genes from the appendicitis and control patients was analyzed in blood samples from 343 patients, 100 with appendicitis, and 243 with non-specific abdominal pain, using TaqMan SNP genotyping assays.
RESULTS: Associations with appendicitis were found for SNPs IL-13 rs1800925 with odds ratio (OR) 6.02 (95% CI 1.52-23.78) for T/T versus C/C + T/T, for IL-17 rs2275913 with OR 2.38 (CI 1.24-4.57) for A/A vs G/G + GA, for CCL22 rs223888 with OR 0.12 (0.02-0.90), and for A/A vs G/G + GA. Signs of effect modification of age for the association with appendicitis were found for IL-13 rs1800925 and CTLA4 rs3087243. Stratified analysis showed difference in association with severity of disease for IL-17 rs2275913 and CD44 rs187115.
CONCLUSIONS: The association of gene variants on risk of appendicitis and its severity suggest an etiologic role of genetically regulated inflammatory response. This may have implications for understanding the prognosis of untreated appendicitis as a possible self-limiting disorder and for understanding the inverse association of appendicitis with ulcerative colitis.

Entities:  

Keywords:  Appendicitis; Gene polymorphism; Inflammatory bowel disease; Pathophysiology

Year:  2019        PMID: 31845023     DOI: 10.1007/s00384-019-03473-1

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  45 in total

Review 1.  The natural history and traditional management of appendicitis revisited: spontaneous resolution and predominance of prehospital perforations imply that a correct diagnosis is more important than an early diagnosis.

Authors:  Roland E Andersson
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

2.  Different cytokine profiles in patients with a history of gangrenous or phlegmonous appendicitis.

Authors:  M Rubér; A Berg; C Ekerfelt; G Olaison; R E Andersson
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

3.  Increased expression of interleukin 17 in inflammatory bowel disease.

Authors:  S Fujino; A Andoh; S Bamba; A Ogawa; K Hata; Y Araki; T Bamba; Y Fujiyama
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

4.  Protein Expression and Genetic Variation of IL32 and Association with Colorectal Cancer in Swedish Patients.

Authors:  Levar Shamoun; Blanka Kolodziej; Roland E Andersson; Jan Dimberg
Journal:  Anticancer Res       Date:  2018-01       Impact factor: 2.480

Review 5.  CTLA-4 and MDR1 polymorphisms increase the risk for ulcerative colitis: A meta-analysis.

Authors:  Jia-Jun Zhao; Di Wang; Hui Yao; Da-Wei Sun; Hong-Yu Li
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

6.  Genetic variants of toll-like receptor 2 and 5, helicobacter pylori infection, and risk of gastric cancer and its precursors in a chinese population.

Authors:  Hong-Mei Zeng; Kai-Feng Pan; Yang Zhang; Lian Zhang; Jun-Ling Ma; Tong Zhou; Hui-Juan Su; Wen-Qing Li; Ji-You Li; Markus Gerhard; Meinhard Classen; Wei-Cheng You
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10-12       Impact factor: 4.254

7.  Polymorphisms in cytokine genes and serum cytokine levels among New Mexican women with and without breast cancer.

Authors:  Esther Erdei; Huining Kang; Angela Meisner; Kirsten White; Gavin Pickett; Cynthia Baca; Melanie Royce; Marianne Berwick
Journal:  Cytokine       Date:  2010-04-24       Impact factor: 3.861

8.  Polymorphisms in metalloproteinase-9 are associated with the risk for asthma in Mexican pediatric patients.

Authors:  Silvia Jiménez-Morales; Nora Martínez-Aguilar; Roberto Gamboa-Becerra; Juan Luis Jiménez-Ruíz; Diana López-Ley; Hong Lou; Yolanda Saldaña-Alvarez; Michael Dean; Lorena Orozco
Journal:  Hum Immunol       Date:  2013-04-29       Impact factor: 2.850

Review 9.  Interleukin and interleukin receptor gene polymorphisms in inflammatory bowel diseases susceptibility.

Authors:  Lili Magyari; Erzsebet Kovesdi; Patricia Sarlos; Andras Javorhazy; Katalin Sumegi; Bela Melegh
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

10.  A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation.

Authors:  J Luis Espinoza; Akiyoshi Takami; Katsuya Nakata; Makoto Onizuka; Takakazu Kawase; Hideki Akiyama; Koichi Miyamura; Yasuo Morishima; Takahiro Fukuda; Yoshihisa Kodera; Shinji Nakao
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

View more
  3 in total

1.  An Evaluation of Serum IgE and Th2-Associated Interleukins in Children With Uncomplicated and Complicated Appendicitis.

Authors:  Johanna Gudjonsdottir; Bodil Roth; Gustav Lovén; Bodil Ohlsson; Lars Hagander; Martin Salö
Journal:  Front Pediatr       Date:  2022-05-02       Impact factor: 3.569

2.  Use of gene expression profiling to identify candidate genes for pretherapeutic patient classification in acute appendicitis.

Authors:  N Kiss; M Minderjahn; J Reismann; J Svensson; T Wester; K Hauptmann; M Schad; J Kallarackal; H von Bernuth; M Reismann
Journal:  BJS Open       Date:  2021-01-08

3.  The appendix-mucosal immunity and tolerance in the gut: consequences for the syndromes of appendicitis and its epidemiology.

Authors:  Alan de Costa
Journal:  ANZ J Surg       Date:  2022-02-13       Impact factor: 2.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.